$460M
$684,000
0.0% of portfolio
122,892
Q4 2023
Added 14.46%
$6.37B
$10.8 Million
0.0% of portfolio
85,059
Q4 2023
Added 91.92%
$608M
$559,000
0.0% of portfolio
57,383
Q4 2023
Reduced 39.46%
$186M
$12,000
0.0% of portfolio
1,248
Q2 2024
Added 3.53%
$1.32B
$625,000
0.0% of portfolio
9,807
Q4 2023
Reduced 12.68%
$485M
$13,000
0.0% of portfolio
1,743
Q2 2023
Reduced 20.59%
$3.49B
$7.1 Million
0.0% of portfolio
401,023
Q4 2023
Added 1.9%
-
$0
0.0% of portfolio
-
Q1 2025
New
$176M
$40,000
0.0% of portfolio
6,148
Q4 2023
Added 1,400.6%
$2.73B
$1.62 Million
0.0% of portfolio
51,259
Q4 2023
Reduced 46.91%
$3.37B
$5.9 Million
0.0% of portfolio
166,738
Q4 2023
Reduced 34.82%
$864M
$901,000
0.0% of portfolio
41,949
Q4 2023
Added 3.05%
$959M
$1.52 Million
0.0% of portfolio
40,399
Q4 2023
Added 5.16%
$4.52B
$1.49 Million
0.0% of portfolio
62,449
Q4 2023
Reduced 10.0%
$202M
$15,000
0.0% of portfolio
765
Q2 2023
New
$4.62B
$5.58 Million
0.0% of portfolio
23,805
Q4 2023
Added 20.47%
$3.66B
$2.71 Million
0.0% of portfolio
51,158
Q4 2023
Reduced 8.46%
$682M
$400,000
0.0% of portfolio
102,056
Q4 2023
Reduced 35.5%
$115M
$12,000
0.0% of portfolio
1,102
Q2 2023
New
Rigel Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.26%
$1.63B
$1.68 Million
0.0% of portfolio
212,089
Q2 2024
Reduced 94.23%
$524M
$218,000
0.0% of portfolio
7,500
Q4 2023
Reduced 31.0%
$415M
$15,000
0.0% of portfolio
4,492
Q4 2023
Added 78.72%
$101M
$14,000
0.0% of portfolio
13,020
Q4 2023
Reduced 21.61%
$2.29B
$2.06 Million
0.0% of portfolio
83,392
Q4 2023
Reduced 7.36%
$2.34B
$2.47 Million
0.0% of portfolio
347,441
Q4 2023
Reduced 43.26%
$520M
$442,000
0.0% of portfolio
95,829
Q4 2023
Reduced 13.37%
$5.08B
$5.85 Million
0.0% of portfolio
806,230
Q4 2023
Added 25.56%
$3.15B
$13.4 Million
0.0% of portfolio
166,204
Q4 2023
Reduced 41.83%
$1.24B
$6.26 Million
0.0% of portfolio
792,876
Q4 2023
Added 49.09%
$3.5B
$1.46 Million
0.0% of portfolio
775,923
Q4 2023
Added 31.85%
$259M
$66,000
0.0% of portfolio
4,010
Q4 2023
Added 249.85%
-
$0
0.0% of portfolio
-
Q2 2024
New
$2.08B
$7.21 Million
0.0% of portfolio
597,384
Q4 2023
Reduced 5.51%
$22.1B
$7.21 Million
0.0% of portfolio
403,240
Q4 2023
Reduced 23.43%
$237M
$817,000
0.0% of portfolio
122,627
Q4 2023
Reduced 45.82%
$170M
$12,000
0.0% of portfolio
746
Q4 2023
Reduced 24.53%
$1.22B
$3.16 Million
0.0% of portfolio
46,756
Q4 2023
Added 31.6%
$8.09B
$6.2 Million
0.0% of portfolio
614,430
Q4 2023
Reduced 52.16%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 24.14%
$1.01B
$1.25 Million
0.0% of portfolio
227,287
Q4 2023
Added 4.11%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.92%
$2.58B
$356,000
0.0% of portfolio
50,354
Q2 2024
Reduced 42.77%
$39.6M
$4,000
0.0% of portfolio
1,465
Q2 2024
Reduced 6.28%
$447M
$2.51 Million
0.0% of portfolio
242,157
Q4 2023
Added 27.05%
$2.14B
$9.15 Million
0.0% of portfolio
171,225
Q4 2023
Reduced 6.97%
$672M
$375,000
0.0% of portfolio
6,639
Q4 2023
Added 87.35%
$932M
$1.02 Million
0.0% of portfolio
95,107
Q4 2023
Reduced 89.04%
$0
$6.57 Million
0.0% of portfolio
343,975
Q4 2023
Reduced 4.16%
$203M
$1.07 Million
0.0% of portfolio
42,453
Q4 2023
Reduced 49.25%